The use of a modification of the Patient Enablement Instrument in asthma

John Andrew Francis Haughney* (Corresponding Author), P. Cotton, Jan Paul Rosen, Ken Morrison, David Price

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)


To ascertain if the Patient Enablement Instrument (PEI) could be adapted for use in asthma management, and to use it to evaluate "enablement" in patients with asthma randomised to either a fixed or adjustable medication dosing regime.
The original Patient Enablement Instrument was modified by making a minor change to the opening statement. 228 adults with asthma from 72 UK general practices were recruited to the study. The internal and external consistencies of the modified PEI were assessed. Individual scores were compared across treatment groups.
The modified PEI had high internal consistency. There was a significant correlation between modified PEI total score and change in Mini Asthma Quality of Life Questionnaire. A significantly greater proportion of patients using adjustable medication dosing had a clinically relevant treatment benefit.
The Patient Enablement Instrument can be used to measure "enablement" in asthma.
Original languageEnglish
Pages (from-to)89-92
Number of pages4
JournalPrimary Care Respiratory Journal
Issue number2
Early online date13 Mar 2007
Publication statusPublished - Apr 2007

Bibliographical note

This study was funded by AstraZeneca UK.


  • Ashtma
  • Validation studies
  • Enablement
  • Self management plan


Dive into the research topics of 'The use of a modification of the Patient Enablement Instrument in asthma'. Together they form a unique fingerprint.

Cite this